Manual Wheelchair (W45)

K252825 · Jiangsu Jumao X-Care Medical Equipment Co., , Ltd. · IOR · Dec 5, 2025 · Physical Medicine

Device Facts

• Record ID: K252825
• Device Name: Manual Wheelchair (W45)
• Applicant: Jiangsu Jumao X-Care Medical Equipment Co., , Ltd.
• Product Code: IOR · Physical Medicine
• Decision Date: Dec 5, 2025
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 890.3850
• Device Class: Class 1
• Attributes: Therapeutic

Intended Use

The W45 Manual Wheelchair is to provide mobility to persons limited to a sitting position.

Device Story

W45 Manual Wheelchair is a mechanical mobility aid for adults limited to a sitting position. Device features aluminum frame, four wheels, nylon upholstery, and polypropylene hand grips/pedals. Propelled by caregiver via rear push handles. Includes hand brake levers on push handles with squeeze-locking mechanism for parking. Used in indoor and outdoor environments. Provides mobility by replacing walking. Healthcare providers or caregivers operate the device to transport patients, improving patient mobility and independence.

Clinical Evidence

Bench testing only. No clinical data. Performance verified via ISO 7176-1, -3, -5, -7, -8, -11, -13, -15, -22, and ISO 16840-10. Biocompatibility assessed per ISO 10993-1 and FDA 2023 guidance.

Technological Characteristics

Mechanical wheelchair; aluminum frame; nylon upholstery (flame resistant); polypropylene hand grips/pedals. Features: foldable frame, quick-release rear axle, hand-operated squeeze-locking brakes. Dimensions: 1010mm x 610mm x 920mm. Weight capacity: 115kg. Standards: ISO 7176 series (stability, brakes, dimensions, strength, dummies, friction, labeling), ISO 16840-10 (ignition resistance).

Indications for Use

Indicated for adults (age ≥22 years) limited to a sitting position requiring mobility assistance.

Regulatory Classification

Identification

A mechanical wheelchair is a manually operated device with wheels that is intended for medical purposes to provide mobility to persons restricted to a sitting position.

Predicate Devices

• Manual Wheelchair (K181795)

Submission Summary (Full Text)

{0}

FDA U.S. FOOD & DRUG ADMINISTRATION

December 5, 2025

Jiangsu Jumao X-Care Medical Equipment Co., Ltd.
% Shouqiu Xiang
Official Correspondent
Shanghai SUNGO Management Consulting Co., Ltd.
14th Floor, Dongfang Building, 1500# Century Ave.
Shanghai, 200122
China

Re: K252825
Trade/Device Name: Manual Wheelchair (Model W45)
Regulation Number: 21 CFR 890.3850
Regulation Name: Mechanical wheelchair
Regulatory Class: Class I, reserved
Product Code: IOR
Dated: September 5, 2025
Received: September 5, 2025

Dear Shouqiu Xiang:

We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

U.S. Food & Drug Administration
10903 New Hampshire Avenue
Silver Spring, MD 20993
www.fda.gov

{1}

K252825 - Shouqiu Xiang
Page 2

Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device" (https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download).

Your device is also subject to, among other requirements, the Quality System (QS) regulation (21 CFR Part 820), which includes, but is not limited to, 21 CFR 820.30, Design controls; 21 CFR 820.90, Nonconforming product; and 21 CFR 820.100, Corrective and preventive action. Please note that regardless of whether a change requires premarket review, the QS regulation requires device manufacturers to review and approve changes to device design and production (21 CFR 820.30 and 21 CFR 820.70) and document changes and approvals in the device master record (21 CFR 820.181).

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reporting-combination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050.

All medical devices, including Class I and unclassified devices and combination product device constituent parts are required to be in compliance with the final Unique Device Identification System rule ("UDI Rule"). The UDI Rule requires, among other things, that a device bear a unique device identifier (UDI) on its label and package (21 CFR 801.20(a)) unless an exception or alternative applies (21 CFR 801.20(b)) and that the dates on the device label be formatted in accordance with 21 CFR 801.18. The UDI Rule (21 CFR 830.300(a) and 830.320(b)) also requires that certain information be submitted to the Global Unique Device Identification Database (GUDID) (21 CFR Part 830 Subpart E). For additional information on these requirements, please see the UDI System webpage at https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance/unique-device-identification-system-udi-system.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-devices/medical-device-safety/medical-device-reporting-mdr-how-report-medical-device-problems.

For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-

{2}

K252825 - Shouqiu Xiang
Page 3

assistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email ([e-mail]) or phone [phone] or 301-796-7100).

Sincerely,

Tushar Bansal -S

Tushar Bansal, PhD
Acting Assistant Director, Acute Injury Devices Team
DHT5B: Division of Neuromodulation and
Physical Medicine Devices
OHT5: Office of Neurological and
Physical Medicine Devices
Office of Product Evaluation and Quality
Center for Devices and Radiological Health

Enclosure

{3}

FORM FDA 3881 (8/23)
Page 1 of 1
PSC Publishing Services [phone]
EF

| DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Indications for Use | Form Approved: OMB No. 0910-0120 Expiration Date: 07/31/2026 See PRA Statement below. |
| --- | --- |
| 510(k) Number (if known) K252825 | |
| Device Name Manual Wheelchair (Model W45) | |
| Indications for Use (Describe) The W45 Manual Wheelchair is to provide mobility to persons limited to a sitting position. | |
| Type of Use (Select one or both, as applicable) ☐ Prescription Use (Part 21 CFR 801 Subpart D) ☑ Over-The-Counter Use (21 CFR 801 Subpart C) | |
| CONTINUE ON A SEPARATE PAGE IF NEEDED. | |
| This section applies only to requirements of the Paperwork Reduction Act of 1995. *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.* | |
| The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to: Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff [e-mail] | |
| "An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number." | |

{4}

510(K) Summary

Prepared on 2025/12/2

## Applicant Information:

Jiangsu Jumao X-Care Medical Equipment Co., Ltd.
Address: No.36 Danyan Road, Danyang City, Jiangsu, P.R. China

Device Name: Manual Wheelchair
Model: W45
Regulatory Information
Classification Name: Mechanical Wheelchair
Regulatory Class: I
Product code: IOR
Regulation Number: 890.3850
Review Panel: Physical Medicine

## Substantial Equivalence Information:

Predicate Device: K181795
Manual Wheelchair
Sichuan AST Medical Equipment Co., Ltd.

## Device Overview

The W45 Manual Wheelchair is a chair with wheels, designed to be a replacement for walking, where it is propelled by a caregiver using the rear push handles. The device is intended for adults only (age ≥22 years). W45 is a mechanical wheelchair including four wheels, features an aluminum frame, polypropylene hand grip and foot pedals, and a nylon upholstery that is flame resistant. W45 has a physical dimension of 1010mm × 610mm × 920mm (overall length × overall width × handgrip height) with the seat itself has a dimension of 470mm × 457mm × 449mm (effective depth × effective width × height at front edge). The device has a weight capacity of 115 kilograms, and weighs about 12 kilograms. The armrest is non flip back/non height adjustable. Rear axle is offset axle, quick release axle. The device features hand brake levers on the rear push handles, with a squeeze-locking mechanism that functions as a parking brake.

## Indications for use

The W45 Manual Wheelchair is to provide mobility to persons limited to a sitting position.

1 / 5

{5}

# 1. Product Parameters

Table 1 General Comparison

| Elements of Comparison | Subject Device (K252825) | Predicate Device (K181795) | Remark |
| --- | --- | --- | --- |
| Manufacturer | Jiangsu Jumao X Care Medical Equipment Co., Ltd. | Sichuan AST Medical Equipment Co., Ltd. | -- |
| Common or Usual name | Manual Wheelchair | Manual Wheelchair | -- |
| Classification | Class I | Class I | Same |
| Classification regulation | 21 CFR 890.3850 | 21 CFR 890.3850 | Same |
| Product code | IOR | IOR | Same |
| Indications for use | The W45 Manual Wheelchair is to provide mobility to persons limited to a sitting position. | It is to provide mobility to persons limited to a sitting position. | Same |
| Use condition | indoor and outdoor use | indoor and outdoor use | Same |
| Control Mode | Mechanical | Mechanical | Same |
| Model(s) | W45 | MA012 | -- |
| Overall Dimensions (Length×Width×Height) (inch) | 39.8×24×36.2 (1010mm*610mm*920 mm) | 46×25×35 | Similar Minor difference on wheelchair dimension will not cause different performance. All safety and performance have been validated with the maximum rated weight dummy. |
| Total weight | 12kg | 17.2kg/38lbs | Similar Different weight of the device do not raise the safety and effectiveness of the device. |

{6}

| Max loading weight | 115kg (250lbs) | 300lbs/136kg | Similar Difference on loading weight will not cause different performance. All safety and performance have been validated with the maximum loading weight. |
| --- | --- | --- | --- |
| Effective Seat width (inch) | 18 (457mm) | 16,18,20 | Similar Minor difference on dimension of wheels will not cause different performance. |
| Seat height (inch) | 17.7(449mm) | 19.7 | |
| Front wheel dimension (inch) | 7.9 (200mm) | 6,7,8 | |
| Rear wheel dimension (inch) | 12.2 (310mm) | 20,22,24 | |
| Frame type | foldable | foldable | Same |
| Back style | Fixed | Model MS019: Fixed Model MA012: Adjustable | Same |
| Wheel construction | Quick release | Quick release | Same |
| Armrest style | Fixed | Adjustable | Same |
| Main frame material | Aluminum | Aluminum | Same |
| Backrest, Seat cushion | Nylon | Nylon cushion | Same |
| Backrest style | Fixed | Adjustable | Similar The slight difference on back style do not raise the safety and effectiveness of the device. |
| Safety Feature | Hand brakes with locking position for parking | Manual Wheel Lock | Same |
| Performance | Comply with: ISO7176-1 ISO7176-3 ISO7176-5 ISO7176-7 ISO7176-8 ISO7176-11 | Comply with: ISO7176-1 ISO7176-3 ISO7176-5 ISO7176-7 ISO7176-8 ISO7176-11 | Same |

3 / 5

{7}

4 / 5

Table 2 safety comparison

| Item | Subject Device | Predicate Device | Results |
| --- | --- | --- | --- |
| Biocompatibility | The biocompatibility of the subject device is based on the use of low-biocompatibility-risk materials in accordance with Attachment G of FDA’s 2023 Biocompatibility Guidance. | All user directly contacting materials are compliance with ISO10993-5 and ISO10993-10 requirements. | S.E. |
| Performance | ISO 7176 -1/-3/-5/-7/-8/-11/-13/-15/-22, ISO 16840-10 | ISO 7176 -1/-3/-5/-7/-8/-11/-13/-15/-22, 16840-10 | S.E. |
| Label and labeling | Conforms to FDA Regulatory requirements | Conforms to FDA Regulatory requirements | S.E. |

## 2. Substantial Equivalence Discussion

The proposed device and predicate device are complying to the same ISO standards, ISO 7176-1, ISO 7176-3, ISO 7176-5, ISO 7176-7, ISO 7176-8, ISO 7176-10, ISO 7176-11, ISO 7176-13, ISO 7176-15, ISO 16840-10 and FDA guidance.

The proposed device performs in a similar manner to the predicate device. All these tests have corresponding requirements/ control criteria following above mentioned standards. And the test results show that the subject product is substantially equivalent to the predicate device in performance.

The performance testing demonstrates that the subject device is substantially equivalent to the predicate devices regarding Static ability (tipping angle), Dimension and weight, Dimension of wheel Static, impact and fatigue strengths, Dummy, friction of test surfaces, Documentation and labeling, Resistance to ignition.

The non-clinical laboratory data support the safety and performance of the subject device and demonstrate that the subject device should perform as intended in the specified use conditions.

## 3. Summary of non-clinical testing

The following performance data were provided to verify that the proposed device met all design specifications and provided support of the substantial equivalence determination.

ISO 7176-1:2014 Wheelchairs - Part 1: Determination of static stability

ISO 7176-3:2012 Wheelchairs - Part 3: Determination of effectiveness of brakes

ISO 7176-5:2008 Wheelchairs - Part 5: Determination of dimensions, mass and

{8}

maneuvering space

ISO 7176-7:1998 Wheelchairs - Part 7: Measurement of seating and wheel dimensions
ISO 7176-8:2014 Wheelchairs - Part 8: Requirements and test methods for static, impact and fatigue strength
ISO 7176-11:2012 Wheelchairs -- Part 11: Test dummies
ISO 7176-13:1989 Wheelchairs - Part 13: Determination of coefficient of friction of test surfaces.
ISO 7176-15:1996 Wheelchairs - Part 15: Requirements for information disclosure, documentation and labeling.
ISO 16840-10:2021 Wheelchair seating - Part 10: Resistance to ignition of postural support devices - Requirements and test method
ISO 7176-22 : 2014 Wheelchairs-Part 22: Set-up procedures

## Biocompatibility of tissue-contacting materials

The biocompatibility of the subject device is based on the use of low-biocompatibility-risk materials in accordance with Attachment G of FDA's 2023 Biocompatibility Guidance ("Use of International Standard ISO 10993-1, 'Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process'").

## 4. Substantial Equivalence Conclusion

Based on the comparison and analysis above, the proposed device is determined to be Substantially Equivalent (SE) to the predicate devices, K181795 Manual Wheelchair from Sichuan AST Medical Equipment Co., Ltd.

5 / 5